Drug Pipeline

Adebrelimab Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-10 NCT07638436 Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally… Phase 2 Recruiting
Active Studies by Phase
Phase 3
1
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07229625 A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing… Advanced Biliary Tract Cancer Recruiting
Phase 2
NCT07110571 A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as… Gastric Cancer Recruiting
NCT07071714 A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in… Colorectal Cancer Recruiting
NCT07638436 Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally… Esophageal Squamous Cell Carcinoma (ESCC) Recruiting
NCT07357532 Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided… Small Cell Lung Carcinoma Not Yet Recruiting
Sponsors Running Adebrelimab Injection Trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (3) Peking University Cancer Hospital & Institute (1) Sun Yat-sen University (1)
Disease Areas
Colorectal Cancer (1) Gastric Cancer (1) Cholangiocarcinoma (1) Small Cell Lung Cancer (1) Lung Cancer (1)
Get alerts when Adebrelimab Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free